AI Science Tracker

ML prioritization identifies two antimicrobial peptide candidates

Amsterdam University Medical Centre; Leiden University; Leiden University Medical Center · 20 Nov 2025 · biology

Discovery

ML prioritization identifies two antimicrobial peptide candidates

CalcAMP ranked 16,384 14-residue sequences in a researcher-defined LL-37-derived design space bounded by patent WO2015088344. Researchers selected GDST-038 and GDST-045 for laboratory tests; the paper reports activity against tested bacteria and elimination of detectable adherent S. aureus in a 3D human epidermal infection model at concentrations of at least 15 µM. Retro-inverso variants were prepared and tested after selection. These results do not establish human safety or clinical efficacy, and exact sequence-level patent priority remains open.

Technology: CalcAMP machine-learning activity ranking

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The primary article reports in-vitro antimicrobial testing, biofilm assays and a 3D human epidermal infection model for selected parent/retro-inverso peptides.
  • Still unknown: These are in-vitro and tissue-model findings, not clinical efficacy or human safety. Sequence-level patent scope and independent replication are not established.
  • AI role: CalcAMP ranked peptide sequences by predicted antimicrobial activity; researchers selected and experimentally tested two lead sequences and retro-inverso variants.

Evidence sources: https://www.mdpi.com/2079-6382/14/11/1172

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 16 Nov 2026. Review scope: Primary MDPI full article, abstract/results and author-affiliation block reviewed..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.